

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | lymphangiogenesis (GO:0001946) | 4.29738999 |
| 2 | neural crest cell development (GO:0014032) | 4.00592536 |
| 3 | mesenchymal cell development (GO:0014031) | 3.84566759 |
| 4 | response to gravity (GO:0009629) | 3.55049410 |
| 5 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.52906633 |
| 6 | actin-myosin filament sliding (GO:0033275) | 3.51195782 |
| 7 | muscle filament sliding (GO:0030049) | 3.51195782 |
| 8 | blood vessel maturation (GO:0001955) | 3.50831872 |
| 9 | endocardial cushion morphogenesis (GO:0003203) | 3.33990386 |
| 10 | muscle cell cellular homeostasis (GO:0046716) | 3.33602420 |
| 11 | stem cell development (GO:0048864) | 3.30528897 |
| 12 | vascular smooth muscle contraction (GO:0014829) | 3.28239831 |
| 13 | Notch signaling involved in heart development (GO:0061314) | 3.22459616 |
| 14 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.21366826 |
| 15 | kidney mesenchyme development (GO:0072074) | 3.20214906 |
| 16 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.12835072 |
| 17 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.10088560 |
| 18 | wound healing, spreading of epidermal cells (GO:0035313) | 3.09810231 |
| 19 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 3.09652990 |
| 20 | regulation of cardioblast proliferation (GO:0003264) | 3.09652990 |
| 21 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.05190024 |
| 22 | protein targeting to Golgi (GO:0000042) | 3.03754031 |
| 23 | negative regulation of inclusion body assembly (GO:0090084) | 3.03221085 |
| 24 | cardiac epithelial to mesenchymal transition (GO:0060317) | 3.00750591 |
| 25 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 2.99813907 |
| 26 | collagen fibril organization (GO:0030199) | 2.99656783 |
| 27 | muscle cell fate commitment (GO:0042693) | 2.97260654 |
| 28 | metanephric mesenchyme development (GO:0072075) | 2.94812827 |
| 29 | somite development (GO:0061053) | 2.94622693 |
| 30 | notochord development (GO:0030903) | 2.90218033 |
| 31 | relaxation of cardiac muscle (GO:0055119) | 2.85584323 |
| 32 | establishment of protein localization to Golgi (GO:0072600) | 2.85117554 |
| 33 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.83778077 |
| 34 | protein refolding (GO:0042026) | 2.83603598 |
| 35 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.82396453 |
| 36 | cell migration involved in heart development (GO:0060973) | 2.80232453 |
| 37 | mesenchyme morphogenesis (GO:0072132) | 2.79595349 |
| 38 | ventricular septum morphogenesis (GO:0060412) | 2.77831546 |
| 39 | negative regulation of protein localization to cell surface (GO:2000009) | 2.76721918 |
| 40 | outflow tract morphogenesis (GO:0003151) | 2.76176665 |
| 41 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.75186903 |
| 42 | regulation of cell communication by electrical coupling (GO:0010649) | 2.73646973 |
| 43 | response to muscle activity (GO:0014850) | 2.73428175 |
| 44 | negative regulation of axon guidance (GO:1902668) | 2.73378234 |
| 45 | regulation of relaxation of muscle (GO:1901077) | 2.73250031 |
| 46 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.71588089 |
| 47 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.71536511 |
| 48 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.71460466 |
| 49 | positive regulation of protein autophosphorylation (GO:0031954) | 2.71110404 |
| 50 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.69055164 |
| 51 | regulation of skeletal muscle contraction (GO:0014819) | 2.68072906 |
| 52 | dermatan sulfate biosynthetic process (GO:0030208) | 2.67231087 |
| 53 | detection of calcium ion (GO:0005513) | 2.67006811 |
| 54 | chondrocyte proliferation (GO:0035988) | 2.65971269 |
| 55 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.65414214 |
| 56 | neuron fate determination (GO:0048664) | 2.64153219 |
| 57 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.63007471 |
| 58 | cardiac muscle cell development (GO:0055013) | 2.62783732 |
| 59 | negative regulation of complement activation (GO:0045916) | 2.60682950 |
| 60 | cell proliferation involved in metanephros development (GO:0072203) | 2.60615543 |
| 61 | ventricular septum development (GO:0003281) | 2.60414496 |
| 62 | artery development (GO:0060840) | 2.59561688 |
| 63 | heart contraction (GO:0060047) | 2.58291609 |
| 64 | heart process (GO:0003015) | 2.58291609 |
| 65 | smooth muscle tissue development (GO:0048745) | 2.56219086 |
| 66 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.56110044 |
| 67 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 2.56037546 |
| 68 | relaxation of smooth muscle (GO:0044557) | 2.55039521 |
| 69 | cardiac cell development (GO:0055006) | 2.52612717 |
| 70 | ventricular cardiac muscle cell development (GO:0055015) | 2.51521881 |
| 71 | regulation of inclusion body assembly (GO:0090083) | 2.50508394 |
| 72 | tonic smooth muscle contraction (GO:0014820) | 2.49527127 |
| 73 | response to inactivity (GO:0014854) | 2.48253367 |
| 74 | synaptic vesicle exocytosis (GO:0016079) | 2.48090541 |
| 75 | glutamate secretion (GO:0014047) | 2.47893722 |
| 76 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.47704000 |
| 77 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.47584548 |
| 78 | membrane assembly (GO:0071709) | 2.45970509 |
| 79 | anterior/posterior axis specification, embryo (GO:0008595) | 2.45693143 |
| 80 | muscle tissue morphogenesis (GO:0060415) | 2.44828624 |
| 81 | positive regulation of muscle hypertrophy (GO:0014742) | 2.44755628 |
| 82 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.44755628 |
| 83 | regulation of cell proliferation involved in heart morphogenesis (GO:2000136) | 2.43989853 |
| 84 | regulation of heart morphogenesis (GO:2000826) | 2.43959771 |
| 85 | heart valve morphogenesis (GO:0003179) | 2.43436139 |
| 86 | artery smooth muscle contraction (GO:0014824) | 2.42789713 |
| 87 | positive regulation of vesicle fusion (GO:0031340) | 2.42325328 |
| 88 | positive regulation of vascular permeability (GO:0043117) | 2.41080182 |
| 89 | relaxation of muscle (GO:0090075) | 2.40774064 |
| 90 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.40562899 |
| 91 | sprouting angiogenesis (GO:0002040) | 2.40213107 |
| 92 | vocalization behavior (GO:0071625) | 2.39161312 |
| 93 | neuronal stem cell maintenance (GO:0097150) | 2.39159810 |
| 94 | cardiac myofibril assembly (GO:0055003) | 2.39082635 |
| 95 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.36280073 |
| 96 | positive regulation of astrocyte differentiation (GO:0048711) | 2.36015250 |
| 97 | regulation of female gonad development (GO:2000194) | 2.35918749 |
| 98 | limb bud formation (GO:0060174) | 2.34719440 |
| 99 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G- | 2.34573118 |
| 100 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.33853732 |
| 101 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.33366038 |
| 102 | cell proliferation involved in kidney development (GO:0072111) | 2.32279903 |
| 103 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.31133703 |
| 104 | negative regulation of cartilage development (GO:0061037) | 2.31118847 |
| 105 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.30132367 |
| 106 | regulation of membrane repolarization (GO:0060306) | 2.29974753 |
| 107 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.29889395 |
| 108 | cardiac septum development (GO:0003279) | 2.29420438 |
| 109 | positive regulation of cartilage development (GO:0061036) | 2.29204094 |
| 110 | actin filament-based movement (GO:0030048) | 2.29063269 |
| 111 | regulation of sarcomere organization (GO:0060297) | 2.28331315 |
| 112 | sulfation (GO:0051923) | 2.27124220 |
| 113 | embryonic heart tube development (GO:0035050) | 2.26145909 |
| 114 | dermatan sulfate metabolic process (GO:0030205) | 2.26008746 |
| 115 | regulation of axon guidance (GO:1902667) | 2.25475096 |
| 116 | negative regulation of protein activation cascade (GO:2000258) | 2.25175624 |
| 117 | regulation of cardiac muscle cell differentiation (GO:2000725) | 2.24712795 |
| 118 | atrioventricular valve morphogenesis (GO:0003181) | 2.24525540 |
| 119 | regulation of cardiac muscle contraction (GO:0055117) | 2.23768966 |
| 120 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.23352814 |
| 121 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.22170925 |
| 122 | startle response (GO:0001964) | 2.20473851 |
| 123 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.19751103 |
| 124 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.19751103 |
| 125 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.19617737 |
| 126 | neuronal action potential propagation (GO:0019227) | 2.19531767 |
| 127 | cellular potassium ion homeostasis (GO:0030007) | 2.19013967 |
| 128 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.17968680 |
| 129 | plasma membrane repair (GO:0001778) | 2.17532783 |
| 130 | striatum development (GO:0021756) | 2.17461302 |
| 131 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.16279738 |
| 132 | neuron remodeling (GO:0016322) | 2.15682474 |
| 133 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.13985307 |
| 134 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.13785052 |
| 135 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.13774047 |
| 136 | negative regulation of hormone metabolic process (GO:0032351) | 2.13414254 |
| 137 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.13414254 |
| 138 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.12744886 |
| 139 | myofibril assembly (GO:0030239) | 2.10704062 |
| 140 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.10702429 |
| 141 | positive regulation of potassium ion transport (GO:0043268) | 2.10117435 |
| 142 | regulation of sulfur metabolic process (GO:0042762) | 2.09004380 |
| 143 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.07683655 |
| 144 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.07118616 |
| 145 | regulation of cardiac muscle hypertrophy (GO:0010611) | 2.06257986 |
| 146 | regulation of striated muscle contraction (GO:0006942) | 2.05762377 |
| 147 | urinary tract smooth muscle contraction (GO:0014848) | 2.05686609 |
| 148 | neuron cell-cell adhesion (GO:0007158) | 2.04813406 |
| 149 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.04245681 |
| 150 | response to epinephrine (GO:0071871) | 2.04117373 |
| 151 | synaptic vesicle maturation (GO:0016188) | 2.03372381 |
| 152 | behavioral response to cocaine (GO:0048148) | 2.02773270 |
| 153 | regulation of muscle hypertrophy (GO:0014743) | 2.02285718 |
| 154 | multicellular organism reproduction (GO:0032504) | 2.00732225 |
| 155 | aggressive behavior (GO:0002118) | 2.00513867 |
| 156 | membrane depolarization during action potential (GO:0086010) | 2.00240846 |
| 157 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.00045328 |
| 158 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.00032236 |
| 159 | righting reflex (GO:0060013) | 1.99685564 |
| 160 | regulation of actin filament-based movement (GO:1903115) | 1.99089671 |
| 161 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 1.98716192 |
| 162 | long-term synaptic potentiation (GO:0060291) | 1.98614128 |
| 163 | regulation of synaptic vesicle transport (GO:1902803) | 1.98504561 |
| 164 | sarcomere organization (GO:0045214) | 1.98495686 |
| 165 | regulation of vesicle fusion (GO:0031338) | 1.98109835 |
| 166 | regulation of voltage-gated calcium channel activity (GO:1901385) | 1.98088808 |
| 167 | photoreceptor cell differentiation (GO:0046530) | 1.97474035 |
| 168 | eye photoreceptor cell differentiation (GO:0001754) | 1.97474035 |
| 169 | neurotransmitter secretion (GO:0007269) | 1.97031521 |
| 170 | regulation of cardiac muscle cell contraction (GO:0086004) | 1.96817139 |
| 171 | calcium ion-dependent exocytosis (GO:0017156) | 1.96345091 |
| 172 | neurotransmitter catabolic process (GO:0042135) | 1.95651511 |
| 173 | positive regulation of cation channel activity (GO:2001259) | 1.95251282 |
| 174 | piRNA metabolic process (GO:0034587) | 1.94155436 |
| 175 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 1.93696836 |
| 176 | adrenergic receptor signaling pathway (GO:0071875) | 1.93289270 |
| 177 | regulation of muscle adaptation (GO:0043502) | 1.93273076 |
| 178 | epithelial cilium movement (GO:0003351) | 1.92917773 |
| 179 | glutamate receptor signaling pathway (GO:0007215) | 1.92405299 |
| 180 | regulation of glutamate receptor signaling pathway (GO:1900449) | 1.91862727 |
| 181 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 1.91808917 |
| 182 | actin-mediated cell contraction (GO:0070252) | 1.91726366 |
| 183 | parturition (GO:0007567) | 1.91452428 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.22017371 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.08185844 |
| 3 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.19720961 |
| 4 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.16494139 |
| 5 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.13510152 |
| 6 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.07999039 |
| 7 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 2.01737069 |
| 8 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.00380025 |
| 9 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.97600287 |
| 10 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.97342408 |
| 11 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.91089838 |
| 12 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.89314418 |
| 13 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.89219205 |
| 14 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.85995832 |
| 15 | EWS_26573619_Chip-Seq_HEK293_Human | 1.85655021 |
| 16 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.84787430 |
| 17 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.84485260 |
| 18 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.79420405 |
| 19 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.79119546 |
| 20 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.78822107 |
| 21 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.75886714 |
| 22 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.72530132 |
| 23 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.71824628 |
| 24 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.69020026 |
| 25 | P300_19829295_ChIP-Seq_ESCs_Human | 1.67560470 |
| 26 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.65083941 |
| 27 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.63165300 |
| 28 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.60629793 |
| 29 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.59616447 |
| 30 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.58504782 |
| 31 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.55432589 |
| 32 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.55120728 |
| 33 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.53351982 |
| 34 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.52774257 |
| 35 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.52774257 |
| 36 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.50193766 |
| 37 | FUS_26573619_Chip-Seq_HEK293_Human | 1.50063259 |
| 38 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.48498836 |
| 39 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.48498836 |
| 40 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.46021300 |
| 41 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.45277442 |
| 42 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.45234299 |
| 43 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.44204178 |
| 44 | TP53_16413492_ChIP-PET_HCT116_Human | 1.41082685 |
| 45 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.40099517 |
| 46 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.39896474 |
| 47 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.39546180 |
| 48 | AR_25329375_ChIP-Seq_VCAP_Human | 1.39340660 |
| 49 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.37588481 |
| 50 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.37513815 |
| 51 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.35811867 |
| 52 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.34669844 |
| 53 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.34011783 |
| 54 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.33828576 |
| 55 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.33267950 |
| 56 | CJUN_26792858_Chip-Seq_BT549_Human | 1.32934473 |
| 57 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.32674590 |
| 58 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.31790580 |
| 59 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.30908994 |
| 60 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.30601494 |
| 61 | STAT3_23295773_ChIP-Seq_U87_Human | 1.30174917 |
| 62 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.30035365 |
| 63 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.28653231 |
| 64 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.28318378 |
| 65 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.26694197 |
| 66 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.25561839 |
| 67 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.23167382 |
| 68 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.21380897 |
| 69 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.20898223 |
| 70 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.20759834 |
| 71 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.20052432 |
| 72 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.18658461 |
| 73 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.18034302 |
| 74 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.17847515 |
| 75 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.17649394 |
| 76 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.17260305 |
| 77 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.16672333 |
| 78 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.16480228 |
| 79 | KDM2B_26808549_Chip-Seq_REH_Human | 1.15920618 |
| 80 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.15512630 |
| 81 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.15481397 |
| 82 | VDR_22108803_ChIP-Seq_LS180_Human | 1.15351705 |
| 83 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.13933820 |
| 84 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.13608497 |
| 85 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13449190 |
| 86 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.11926991 |
| 87 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.11488663 |
| 88 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.10613023 |
| 89 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.10157860 |
| 90 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.10037756 |
| 91 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.09873567 |
| 92 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.09624492 |
| 93 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.09027908 |
| 94 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.08412375 |
| 95 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.07313971 |
| 96 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.05761258 |
| 97 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.05755045 |
| 98 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.04953138 |
| 99 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.04640976 |
| 100 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.04591640 |
| 101 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.04466175 |
| 102 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.04164203 |
| 103 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.03602824 |
| 104 | JUN_21703547_ChIP-Seq_K562_Human | 1.03109137 |
| 105 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03010769 |
| 106 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.02349944 |
| 107 | * MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.01330036 |
| 108 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.01218245 |
| 109 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.01218245 |
| 110 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.00331564 |
| 111 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00140537 |
| 112 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.99199543 |
| 113 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.98798775 |
| 114 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.98165892 |
| 115 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.97987881 |
| 116 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.97442448 |
| 117 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.97413664 |
| 118 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.96015378 |
| 119 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.95140865 |
| 120 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.94670997 |
| 121 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94166152 |
| 122 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.94022085 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 3.49557619 |
| 2 | MP0003136_yellow_coat_color | 2.93989894 |
| 3 | MP0000751_myopathy | 2.91366976 |
| 4 | MP0003646_muscle_fatigue | 2.80484472 |
| 5 | MP0005171_absent_coat_pigmentation | 2.57159998 |
| 6 | MP0004859_abnormal_synaptic_plasticity | 2.52810790 |
| 7 | MP0004145_abnormal_muscle_electrophysio | 2.39254263 |
| 8 | MP0000749_muscle_degeneration | 2.38526419 |
| 9 | MP0004215_abnormal_myocardial_fiber | 2.36217661 |
| 10 | MP0003880_abnormal_central_pattern | 2.32050791 |
| 11 | MP0005646_abnormal_pituitary_gland | 2.13921317 |
| 12 | MP0004036_abnormal_muscle_relaxation | 2.12740126 |
| 13 | MP0004484_altered_response_of | 2.12706567 |
| 14 | MP0004270_analgesia | 1.95492047 |
| 15 | MP0009384_cardiac_valve_regurgitation | 1.93487011 |
| 16 | MP0005503_abnormal_tendon_morphology | 1.92752946 |
| 17 | MP0010368_abnormal_lymphatic_system | 1.89841997 |
| 18 | MP0001501_abnormal_sleep_pattern | 1.88795575 |
| 19 | MP0002736_abnormal_nociception_after | 1.87096796 |
| 20 | MP0003635_abnormal_synaptic_transmissio | 1.86398160 |
| 21 | MP0005620_abnormal_muscle_contractility | 1.86186418 |
| 22 | MP0001968_abnormal_touch/_nociception | 1.80612695 |
| 23 | MP0008438_abnormal_cutaneous_collagen | 1.80362024 |
| 24 | MP0009046_muscle_twitch | 1.77913789 |
| 25 | MP0000013_abnormal_adipose_tissue | 1.76445768 |
| 26 | MP0009745_abnormal_behavioral_response | 1.72896480 |
| 27 | MP0001958_emphysema | 1.70760874 |
| 28 | MP0004130_abnormal_muscle_cell | 1.69007158 |
| 29 | MP0005187_abnormal_penis_morphology | 1.68420694 |
| 30 | MP0004084_abnormal_cardiac_muscle | 1.65628330 |
| 31 | MP0005275_abnormal_skin_tensile | 1.62532896 |
| 32 | MP0002972_abnormal_cardiac_muscle | 1.61373132 |
| 33 | MP0009780_abnormal_chondrocyte_physiolo | 1.60650612 |
| 34 | MP0002009_preneoplasia | 1.57998142 |
| 35 | MP0010386_abnormal_urinary_bladder | 1.56719263 |
| 36 | MP0008775_abnormal_heart_ventricle | 1.50535342 |
| 37 | MP0003950_abnormal_plasma_membrane | 1.49959712 |
| 38 | MP0004085_abnormal_heartbeat | 1.49628603 |
| 39 | MP0002063_abnormal_learning/memory/cond | 1.49444317 |
| 40 | MP0002572_abnormal_emotion/affect_behav | 1.49057000 |
| 41 | MP0006054_spinal_hemorrhage | 1.48490217 |
| 42 | MP0003705_abnormal_hypodermis_morpholog | 1.47072693 |
| 43 | MP0002234_abnormal_pharynx_morphology | 1.46587134 |
| 44 | MP0002928_abnormal_bile_duct | 1.43676878 |
| 45 | MP0002282_abnormal_trachea_morphology | 1.42073963 |
| 46 | MP0010030_abnormal_orbit_morphology | 1.39396743 |
| 47 | MP0001984_abnormal_olfaction | 1.37839349 |
| 48 | MP0002822_catalepsy | 1.37494268 |
| 49 | MP0001542_abnormal_bone_strength | 1.35686614 |
| 50 | MP0000733_abnormal_muscle_development | 1.35015887 |
| 51 | MP0002064_seizures | 1.34292250 |
| 52 | MP0002108_abnormal_muscle_morphology | 1.33608591 |
| 53 | MP0002734_abnormal_mechanical_nocicepti | 1.33516831 |
| 54 | MP0001440_abnormal_grooming_behavior | 1.31987489 |
| 55 | MP0005410_abnormal_fertilization | 1.30952302 |
| 56 | MP0002295_abnormal_pulmonary_circulatio | 1.29217040 |
| 57 | MP0002272_abnormal_nervous_system | 1.26713843 |
| 58 | MP0000762_abnormal_tongue_morphology | 1.25876443 |
| 59 | MP0003279_aneurysm | 1.25074278 |
| 60 | MP0008875_abnormal_xenobiotic_pharmacok | 1.24976749 |
| 61 | MP0005330_cardiomyopathy | 1.24608153 |
| 62 | MP0004087_abnormal_muscle_fiber | 1.23940394 |
| 63 | MP0002090_abnormal_vision | 1.21944949 |
| 64 | MP0002106_abnormal_muscle_physiology | 1.20784562 |
| 65 | MP0001502_abnormal_circadian_rhythm | 1.20140126 |
| 66 | MP0000569_abnormal_digit_pigmentation | 1.19866100 |
| 67 | MP0005595_abnormal_vascular_smooth | 1.18630130 |
| 68 | MP0003755_abnormal_palate_morphology | 1.18511990 |
| 69 | MP0005369_muscle_phenotype | 1.18058548 |
| 70 | MP0000230_abnormal_systemic_arterial | 1.17797638 |
| 71 | MP0000750_abnormal_muscle_regeneration | 1.17276328 |
| 72 | MP0000747_muscle_weakness | 1.17222788 |
| 73 | MP0006276_abnormal_autonomic_nervous | 1.16370230 |
| 74 | MP0002332_abnormal_exercise_endurance | 1.15314172 |
| 75 | MP0001486_abnormal_startle_reflex | 1.15306152 |
| 76 | MP0002638_abnormal_pupillary_reflex | 1.13725212 |
| 77 | MP0002938_white_spotting | 1.13652627 |
| 78 | MP0006138_congestive_heart_failure | 1.13474827 |
| 79 | MP0003045_fibrosis | 1.09889178 |
| 80 | MP0003283_abnormal_digestive_organ | 1.08785644 |
| 81 | MP0005085_abnormal_gallbladder_physiolo | 1.08013146 |
| 82 | MP0005623_abnormal_meninges_morphology | 1.05556197 |
| 83 | MP0002067_abnormal_sensory_capabilities | 1.04261652 |
| 84 | MP0005084_abnormal_gallbladder_morpholo | 1.01287533 |
| 85 | MP0005670_abnormal_white_adipose | 1.00682949 |
| 86 | MP0009697_abnormal_copulation | 0.99759190 |
| 87 | MP0005508_abnormal_skeleton_morphology | 0.99025739 |
| 88 | MP0001177_atelectasis | 0.98689136 |
| 89 | MP0001905_abnormal_dopamine_level | 0.97321771 |
| 90 | MP0004233_abnormal_muscle_weight | 0.96944878 |
| 91 | MP0000534_abnormal_ureter_morphology | 0.96931709 |
| 92 | MP0003137_abnormal_impulse_conducting | 0.96919789 |
| 93 | MP0002909_abnormal_adrenal_gland | 0.96634811 |
| 94 | MP0000003_abnormal_adipose_tissue | 0.96033205 |
| 95 | MP0004134_abnormal_chest_morphology | 0.95432213 |
| 96 | MP0004147_increased_porphyrin_level | 0.95270618 |
| 97 | MP0002127_abnormal_cardiovascular_syste | 0.94642893 |
| 98 | MP0008004_abnormal_stomach_pH | 0.94472814 |
| 99 | MP0002735_abnormal_chemical_nociception | 0.93867920 |
| 100 | MP0005386_behavior/neurological_phenoty | 0.93778308 |
| 101 | MP0004924_abnormal_behavior | 0.93778308 |
| 102 | MP0001299_abnormal_eye_distance/ | 0.92268577 |
| 103 | MP0005167_abnormal_blood-brain_barrier | 0.91876576 |
| 104 | MP0002896_abnormal_bone_mineralization | 0.90221628 |
| 105 | MP0000049_abnormal_middle_ear | 0.90043214 |
| 106 | MP0001544_abnormal_cardiovascular_syste | 0.89916051 |
| 107 | MP0005385_cardiovascular_system_phenoty | 0.89916051 |
| 108 | MP0000759_abnormal_skeletal_muscle | 0.88727637 |
| 109 | MP0006072_abnormal_retinal_apoptosis | 0.88504608 |
| 110 | MP0002102_abnormal_ear_morphology | 0.87816844 |
| 111 | MP0002557_abnormal_social/conspecific_i | 0.87750987 |
| 112 | MP0002139_abnormal_hepatobiliary_system | 0.87585680 |
| 113 | MP0009053_abnormal_anal_canal | 0.86835434 |
| 114 | MP0005535_abnormal_body_temperature | 0.85954902 |
| 115 | MP0004510_myositis | 0.85346554 |
| 116 | MP0002269_muscular_atrophy | 0.85161484 |
| 117 | MP0004883_abnormal_blood_vessel | 0.83575220 |
| 118 | MP0002128_abnormal_blood_circulation | 0.82550135 |
| 119 | MP0003091_abnormal_cell_migration | 0.82425341 |
| 120 | MP0003935_abnormal_craniofacial_develop | 0.81807209 |
| 121 | MP0005164_abnormal_response_to | 0.81170364 |
| 122 | MP0005365_abnormal_bile_salt | 0.80979972 |
| 123 | MP0003941_abnormal_skin_development | 0.79957500 |
| 124 | MP0001879_abnormal_lymphatic_vessel | 0.79646844 |
| 125 | MP0001485_abnormal_pinna_reflex | 0.79499673 |
| 126 | MP0003787_abnormal_imprinting | 0.79492013 |
| 127 | MP0005165_increased_susceptibility_to | 0.79195653 |
| 128 | MP0009250_abnormal_appendicular_skeleto | 0.78934615 |
| 129 | MP0000767_abnormal_smooth_muscle | 0.78870413 |
| 130 | MP0000343_altered_response_to | 0.78704489 |
| 131 | MP0003937_abnormal_limbs/digits/tail_de | 0.78422944 |
| 132 | MP0008874_decreased_physiological_sensi | 0.78314661 |
| 133 | MP0004272_abnormal_basement_membrane | 0.78274157 |
| 134 | MP0003690_abnormal_glial_cell | 0.78027210 |
| 135 | MP0003828_pulmonary_edema | 0.77622565 |
| 136 | MP0000579_abnormal_nail_morphology | 0.76090455 |
| 137 | MP0005023_abnormal_wound_healing | 0.74871555 |
| 138 | MP0000163_abnormal_cartilage_morphology | 0.74609508 |
| 139 | MP0000516_abnormal_urinary_system | 0.74175169 |
| 140 | MP0005367_renal/urinary_system_phenotyp | 0.74175169 |
| 141 | MP0002168_other_aberrant_phenotype | 0.69725639 |
| 142 | MP0010630_abnormal_cardiac_muscle | 0.68037187 |
| 143 | MP0000778_abnormal_nervous_system | 0.67771464 |
| 144 | MP0002160_abnormal_reproductive_system | 0.67083475 |
| 145 | MP0005253_abnormal_eye_physiology | 0.66991601 |
| 146 | MP0001529_abnormal_vocalization | 0.66366706 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 4.25765641 |
| 2 | Popliteal pterygium (HP:0009756) | 4.23716340 |
| 3 | Type 2 muscle fiber atrophy (HP:0003554) | 3.84377645 |
| 4 | Focal motor seizures (HP:0011153) | 3.55904376 |
| 5 | Exercise-induced myalgia (HP:0003738) | 3.53189029 |
| 6 | Calf muscle hypertrophy (HP:0008981) | 3.33922794 |
| 7 | Abnormality of the calf musculature (HP:0001430) | 3.33641460 |
| 8 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.24650861 |
| 9 | Abnormality of placental membranes (HP:0011409) | 3.20563759 |
| 10 | Amniotic constriction ring (HP:0009775) | 3.20563759 |
| 11 | Atrial fibrillation (HP:0005110) | 3.18694738 |
| 12 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.16310579 |
| 13 | Absent/shortened dynein arms (HP:0200106) | 3.16310579 |
| 14 | Sudden death (HP:0001699) | 3.08794819 |
| 15 | Muscle fiber atrophy (HP:0100295) | 3.03640907 |
| 16 | Primary atrial arrhythmia (HP:0001692) | 2.95415449 |
| 17 | Aplasia of the phalanges of the hand (HP:0009802) | 2.92269523 |
| 18 | Aplasia involving bones of the extremities (HP:0009825) | 2.92269523 |
| 19 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.92269523 |
| 20 | Muscle fiber inclusion bodies (HP:0100299) | 2.92199735 |
| 21 | Soft skin (HP:0000977) | 2.92131705 |
| 22 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.90522675 |
| 23 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.89568940 |
| 24 | Muscle fiber splitting (HP:0003555) | 2.87711331 |
| 25 | Distal arthrogryposis (HP:0005684) | 2.84787218 |
| 26 | Depressed nasal tip (HP:0000437) | 2.81786730 |
| 27 | Delayed gross motor development (HP:0002194) | 2.75408720 |
| 28 | Hyporeflexia of lower limbs (HP:0002600) | 2.73544149 |
| 29 | Aplasia of the musculature (HP:0100854) | 2.72443070 |
| 30 | Supraventricular tachycardia (HP:0004755) | 2.69259050 |
| 31 | Abnormality of the ischium (HP:0003174) | 2.63005542 |
| 32 | Neonatal short-limb short stature (HP:0008921) | 2.62684937 |
| 33 | Supraventricular arrhythmia (HP:0005115) | 2.62619085 |
| 34 | Weak cry (HP:0001612) | 2.61382840 |
| 35 | Atonic seizures (HP:0010819) | 2.60508913 |
| 36 | Febrile seizures (HP:0002373) | 2.58500658 |
| 37 | Vascular tortuosity (HP:0004948) | 2.57021977 |
| 38 | Type 1 muscle fiber predominance (HP:0003803) | 2.52796929 |
| 39 | Broad metatarsal (HP:0001783) | 2.50524641 |
| 40 | Nemaline bodies (HP:0003798) | 2.49727213 |
| 41 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.45231062 |
| 42 | Epileptic encephalopathy (HP:0200134) | 2.42863310 |
| 43 | Right ventricular cardiomyopathy (HP:0011663) | 2.40876198 |
| 44 | Arterial tortuosity (HP:0005116) | 2.40623322 |
| 45 | EMG: myopathic abnormalities (HP:0003458) | 2.39031755 |
| 46 | Hypoplastic ischia (HP:0003175) | 2.39019792 |
| 47 | Exercise-induced muscle cramps (HP:0003710) | 2.36027631 |
| 48 | Chronic bronchitis (HP:0004469) | 2.34438242 |
| 49 | Round ear (HP:0100830) | 2.32330171 |
| 50 | Follicular hyperkeratosis (HP:0007502) | 2.29262365 |
| 51 | Syncope (HP:0001279) | 2.27364216 |
| 52 | Increased variability in muscle fiber diameter (HP:0003557) | 2.27012264 |
| 53 | True hermaphroditism (HP:0010459) | 2.26421428 |
| 54 | Abnormal ciliary motility (HP:0012262) | 2.26112335 |
| 55 | Aortic dissection (HP:0002647) | 2.25533471 |
| 56 | Malignant hyperthermia (HP:0002047) | 2.24128471 |
| 57 | Focal seizures (HP:0007359) | 2.22647094 |
| 58 | Abnormal finger flexion creases (HP:0006143) | 2.21351250 |
| 59 | Rhinitis (HP:0012384) | 2.20557107 |
| 60 | Distal lower limb amyotrophy (HP:0008944) | 2.20439900 |
| 61 | Thin ribs (HP:0000883) | 2.19706094 |
| 62 | Congenital, generalized hypertrichosis (HP:0004540) | 2.18987592 |
| 63 | Papillary thyroid carcinoma (HP:0002895) | 2.18626248 |
| 64 | Prolonged QT interval (HP:0001657) | 2.17705042 |
| 65 | Absent phalangeal crease (HP:0006109) | 2.16919556 |
| 66 | Aortic aneurysm (HP:0004942) | 2.16716019 |
| 67 | Hyperventilation (HP:0002883) | 2.14993800 |
| 68 | Generalized tonic-clonic seizures (HP:0002069) | 2.11345538 |
| 69 | Limited hip movement (HP:0008800) | 2.10328532 |
| 70 | Neck muscle weakness (HP:0000467) | 2.09899265 |
| 71 | Hypoplasia of the iris (HP:0007676) | 2.09770196 |
| 72 | Fibular aplasia (HP:0002990) | 2.09644322 |
| 73 | Premature rupture of membranes (HP:0001788) | 2.09478581 |
| 74 | Lipoatrophy (HP:0100578) | 2.09102536 |
| 75 | Gowers sign (HP:0003391) | 2.07236522 |
| 76 | Infertility (HP:0000789) | 2.07099800 |
| 77 | Progressive cerebellar ataxia (HP:0002073) | 2.06816457 |
| 78 | Large for gestational age (HP:0001520) | 2.06217214 |
| 79 | Bone cyst (HP:0012062) | 2.04559050 |
| 80 | Left ventricular hypertrophy (HP:0001712) | 2.04260626 |
| 81 | Hemiparesis (HP:0001269) | 2.03195545 |
| 82 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 2.03101079 |
| 83 | Pancreatic fibrosis (HP:0100732) | 2.03059224 |
| 84 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.01277001 |
| 85 | Lower limb amyotrophy (HP:0007210) | 2.00922225 |
| 86 | Pterygium (HP:0001059) | 1.98474178 |
| 87 | Dysmetric saccades (HP:0000641) | 1.98342811 |
| 88 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.96387441 |
| 89 | Hip contracture (HP:0003273) | 1.95736732 |
| 90 | Toxemia of pregnancy (HP:0100603) | 1.94706950 |
| 91 | Muscular dystrophy (HP:0003560) | 1.94043033 |
| 92 | Hyperglycemia (HP:0003074) | 1.93710332 |
| 93 | Bradycardia (HP:0001662) | 1.92612470 |
| 94 | Myotonia (HP:0002486) | 1.92295231 |
| 95 | Oligomenorrhea (HP:0000876) | 1.92162695 |
| 96 | Protrusio acetabuli (HP:0003179) | 1.92098674 |
| 97 | Deformed tarsal bones (HP:0008119) | 1.91422527 |
| 98 | Abnormality of dentin (HP:0010299) | 1.91220207 |
| 99 | Subaortic stenosis (HP:0001682) | 1.90076878 |
| 100 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.90076878 |
| 101 | Gaze-evoked nystagmus (HP:0000640) | 1.89809705 |
| 102 | Calcaneovalgus deformity (HP:0001848) | 1.89797343 |
| 103 | Meningioma (HP:0002858) | 1.88999871 |
| 104 | Medial flaring of the eyebrow (HP:0010747) | 1.88633459 |
| 105 | Limb-girdle muscle weakness (HP:0003325) | 1.88600538 |
| 106 | Nonprogressive disorder (HP:0003680) | 1.86563138 |
| 107 | Male infertility (HP:0003251) | 1.86176120 |
| 108 | Striae distensae (HP:0001065) | 1.85204947 |
| 109 | Cholecystitis (HP:0001082) | 1.85070068 |
| 110 | Abnormal gallbladder physiology (HP:0012438) | 1.85070068 |
| 111 | Increased connective tissue (HP:0009025) | 1.84873967 |
| 112 | Hypoalphalipoproteinemia (HP:0003233) | 1.84632669 |
| 113 | Gait imbalance (HP:0002141) | 1.84258023 |
| 114 | Overgrowth (HP:0001548) | 1.82703856 |
| 115 | Bundle branch block (HP:0011710) | 1.82323235 |
| 116 | Congenital primary aphakia (HP:0007707) | 1.81712200 |
| 117 | Spinal rigidity (HP:0003306) | 1.81567218 |
| 118 | Fatigable weakness (HP:0003473) | 1.80092296 |
| 119 | Abnormality of the neuromuscular junction (HP:0003398) | 1.80092296 |
| 120 | Decreased muscle mass (HP:0003199) | 1.79015060 |
| 121 | Increased corneal curvature (HP:0100692) | 1.77984246 |
| 122 | Keratoconus (HP:0000563) | 1.77984246 |
| 123 | Limb-girdle muscle atrophy (HP:0003797) | 1.77948864 |
| 124 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.77904805 |
| 125 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.77832391 |
| 126 | Absence seizures (HP:0002121) | 1.77818102 |
| 127 | Aortic regurgitation (HP:0001659) | 1.77534605 |
| 128 | Steppage gait (HP:0003376) | 1.76560323 |
| 129 | Pheochromocytoma (HP:0002666) | 1.76414981 |
| 130 | Spondylolisthesis (HP:0003302) | 1.76304411 |
| 131 | Mesomelia (HP:0003027) | 1.75764884 |
| 132 | Fibular hypoplasia (HP:0003038) | 1.74667516 |
| 133 | Ulnar claw (HP:0001178) | 1.74577633 |
| 134 | Pancreatic cysts (HP:0001737) | 1.74228612 |
| 135 | Tubular atrophy (HP:0000092) | 1.74145069 |
| 136 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.73942668 |
| 137 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.73942668 |
| 138 | Cortical dysplasia (HP:0002539) | 1.73603620 |
| 139 | Anxiety (HP:0000739) | 1.73404789 |
| 140 | Dysdiadochokinesis (HP:0002075) | 1.73161120 |
| 141 | Genital tract atresia (HP:0001827) | 1.72997852 |
| 142 | Retinal dysplasia (HP:0007973) | 1.72569143 |
| 143 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.71855728 |
| 144 | Rimmed vacuoles (HP:0003805) | 1.71826409 |
| 145 | Prominent supraorbital ridges (HP:0000336) | 1.71147328 |
| 146 | Wrist flexion contracture (HP:0001239) | 1.68142387 |
| 147 | Aortic valve stenosis (HP:0001650) | 1.68028446 |
| 148 | Knee flexion contracture (HP:0006380) | 1.67897147 |
| 149 | Chorioretinal atrophy (HP:0000533) | 1.66588256 |
| 150 | Scanning speech (HP:0002168) | 1.65609925 |
| 151 | Myokymia (HP:0002411) | 1.65463952 |
| 152 | Vaginal atresia (HP:0000148) | 1.65007925 |
| 153 | Ventricular arrhythmia (HP:0004308) | 1.64917638 |
| 154 | Fetal akinesia sequence (HP:0001989) | 1.64146292 |
| 155 | Difficulty climbing stairs (HP:0003551) | 1.63981542 |
| 156 | Abnormality of the anterior chamber (HP:0000593) | 1.63917951 |
| 157 | Abnormality of midbrain morphology (HP:0002418) | 1.63472359 |
| 158 | Molar tooth sign on MRI (HP:0002419) | 1.63472359 |
| 159 | Muscle stiffness (HP:0003552) | 1.62346205 |
| 160 | Facial diplegia (HP:0001349) | 1.62203604 |
| 161 | Infantile muscular hypotonia (HP:0008947) | 1.61295882 |
| 162 | Abnormal atrioventricular conduction (HP:0005150) | 1.60365258 |
| 163 | Difficulty running (HP:0009046) | 1.60022156 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PNCK | 4.88497610 |
| 2 | TSSK6 | 4.85022903 |
| 3 | WEE1 | 3.22906112 |
| 4 | MUSK | 2.90749551 |
| 5 | MAP3K4 | 2.79796890 |
| 6 | MAP2K7 | 2.59948203 |
| 7 | MAP3K6 | 2.36375882 |
| 8 | PDK3 | 2.33836921 |
| 9 | PDK4 | 2.33836921 |
| 10 | MAPKAPK5 | 2.29478866 |
| 11 | TAOK3 | 2.27660463 |
| 12 | PDK2 | 2.19946845 |
| 13 | OBSCN | 2.15537416 |
| 14 | EPHB2 | 2.13551842 |
| 15 | MAP2K4 | 1.98444090 |
| 16 | EPHA4 | 1.96704829 |
| 17 | CASK | 1.91254463 |
| 18 | NTRK3 | 1.89636779 |
| 19 | DMPK | 1.85816549 |
| 20 | PIK3CA | 1.71440829 |
| 21 | ERBB3 | 1.70686219 |
| 22 | MOS | 1.63566061 |
| 23 | MAP3K12 | 1.62982586 |
| 24 | LIMK1 | 1.60787444 |
| 25 | ERBB4 | 1.55696069 |
| 26 | FER | 1.54628944 |
| 27 | LATS1 | 1.52566399 |
| 28 | EIF2AK3 | 1.52475031 |
| 29 | VRK1 | 1.48649609 |
| 30 | MAP3K9 | 1.44472436 |
| 31 | GRK7 | 1.41996088 |
| 32 | PTK2B | 1.37628741 |
| 33 | BRSK2 | 1.36934506 |
| 34 | PHKG1 | 1.33430734 |
| 35 | PHKG2 | 1.33430734 |
| 36 | SGK2 | 1.29534588 |
| 37 | PAK2 | 1.29478808 |
| 38 | PLK2 | 1.29420735 |
| 39 | PINK1 | 1.28259671 |
| 40 | MAPK15 | 1.25490616 |
| 41 | BMPR2 | 1.23758723 |
| 42 | ARAF | 1.23156182 |
| 43 | PLK3 | 1.21592431 |
| 44 | TTN | 1.18514514 |
| 45 | FRK | 1.18488477 |
| 46 | AKT3 | 1.18163940 |
| 47 | EPHA3 | 1.16849796 |
| 48 | DDR2 | 1.15505837 |
| 49 | SGK223 | 1.14547566 |
| 50 | SGK494 | 1.14547566 |
| 51 | INSRR | 1.14361865 |
| 52 | CAMK2A | 1.13461853 |
| 53 | STK38L | 1.11515967 |
| 54 | NTRK2 | 1.09059017 |
| 55 | TGFBR1 | 1.08905130 |
| 56 | PRKD3 | 1.08024510 |
| 57 | MYLK | 1.07760555 |
| 58 | BRAF | 1.07558959 |
| 59 | PAK3 | 1.04516484 |
| 60 | LMTK2 | 1.04513233 |
| 61 | NEK9 | 1.02118041 |
| 62 | WNK4 | 0.96053057 |
| 63 | MKNK2 | 0.95956995 |
| 64 | MARK1 | 0.95810192 |
| 65 | LATS2 | 0.94696389 |
| 66 | CDK3 | 0.94221035 |
| 67 | MINK1 | 0.93968326 |
| 68 | KSR2 | 0.93294581 |
| 69 | SGK3 | 0.92441607 |
| 70 | BMPR1B | 0.92433311 |
| 71 | MAP3K13 | 0.89985170 |
| 72 | STK39 | 0.89741905 |
| 73 | TRPM7 | 0.87567653 |
| 74 | PIK3CG | 0.85951961 |
| 75 | PRKAA2 | 0.84940798 |
| 76 | NEK6 | 0.84938578 |
| 77 | CAMK2D | 0.83795507 |
| 78 | STK38 | 0.82167844 |
| 79 | DYRK3 | 0.81529499 |
| 80 | CCNB1 | 0.80973853 |
| 81 | WNK1 | 0.78937188 |
| 82 | RAF1 | 0.77097468 |
| 83 | RET | 0.76969725 |
| 84 | GRK5 | 0.75534783 |
| 85 | MAPK13 | 0.75420384 |
| 86 | ADRBK2 | 0.74758593 |
| 87 | STK3 | 0.72615561 |
| 88 | GSK3A | 0.72176800 |
| 89 | MAPK12 | 0.68687332 |
| 90 | CDK8 | 0.66689113 |
| 91 | MAP4K2 | 0.66538320 |
| 92 | WNK3 | 0.66337570 |
| 93 | PRKCE | 0.66258714 |
| 94 | PDGFRA | 0.64539298 |
| 95 | TGFBR2 | 0.64529278 |
| 96 | MAP3K5 | 0.64465259 |
| 97 | MET | 0.64375056 |
| 98 | MAPKAPK3 | 0.64072765 |
| 99 | PKN1 | 0.63108647 |
| 100 | CAMK2G | 0.63107870 |
| 101 | TAOK1 | 0.63040950 |
| 102 | NTRK1 | 0.62701232 |
| 103 | ROCK1 | 0.61990435 |
| 104 | GRK1 | 0.61883469 |
| 105 | CDK5 | 0.61870718 |
| 106 | BCR | 0.61750075 |
| 107 | OXSR1 | 0.61127827 |
| 108 | PRKCG | 0.61084858 |
| 109 | ZAK | 0.60050373 |
| 110 | ROCK2 | 0.58593294 |
| 111 | SGK1 | 0.57789808 |
| 112 | STK24 | 0.57755752 |
| 113 | MAP2K1 | 0.57621960 |
| 114 | MKNK1 | 0.57433068 |
| 115 | MST4 | 0.57177706 |
| 116 | CAMK1G | 0.56574202 |
| 117 | NUAK1 | 0.55958371 |
| 118 | MAP3K1 | 0.55471611 |
| 119 | PRKG1 | 0.55192618 |
| 120 | PTK2 | 0.55147935 |
| 121 | PRKAA1 | 0.54221114 |
| 122 | CAMKK2 | 0.54138717 |
| 123 | FGFR2 | 0.53591269 |
| 124 | PAK6 | 0.53503820 |
| 125 | TRIM28 | 0.51727274 |
| 126 | CAMK1 | 0.51254072 |
| 127 | FES | 0.49672089 |
| 128 | KSR1 | 0.47022332 |
| 129 | TIE1 | 0.46698685 |
| 130 | CAMK2B | 0.46681893 |
| 131 | ADRBK1 | 0.44504536 |
| 132 | TNIK | 0.43761294 |
| 133 | MAPK7 | 0.42956681 |
| 134 | ABL2 | 0.42588239 |
| 135 | CDK9 | 0.41976587 |
| 136 | DAPK2 | 0.40502985 |
| 137 | EIF2AK2 | 0.39795165 |
| 138 | PDGFRB | 0.37302590 |
| 139 | PRKD1 | 0.36258240 |
| 140 | ACVR1B | 0.35551664 |
| 141 | EIF2AK1 | 0.35240460 |
| 142 | NEK1 | 0.32320578 |
| 143 | ABL1 | 0.29912385 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 2.68218478 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.08468022 |
| 3 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.87400387 |
| 4 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.76071932 |
| 5 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.74481364 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 1.72416426 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 1.69437090 |
| 8 | Renin secretion_Homo sapiens_hsa04924 | 1.69197622 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.69098546 |
| 10 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.66380656 |
| 11 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.60725779 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.55920483 |
| 13 | Morphine addiction_Homo sapiens_hsa05032 | 1.55236500 |
| 14 | Circadian rhythm_Homo sapiens_hsa04710 | 1.52012195 |
| 15 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.50403225 |
| 16 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.50180760 |
| 17 | Olfactory transduction_Homo sapiens_hsa04740 | 1.46782739 |
| 18 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.44493331 |
| 19 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.43617601 |
| 20 | Insulin secretion_Homo sapiens_hsa04911 | 1.40284183 |
| 21 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.37528486 |
| 22 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.36345357 |
| 23 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.33112909 |
| 24 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.32699521 |
| 25 | Salivary secretion_Homo sapiens_hsa04970 | 1.29897214 |
| 26 | Cocaine addiction_Homo sapiens_hsa05030 | 1.29806546 |
| 27 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.27438464 |
| 28 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.27288876 |
| 29 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.25930958 |
| 30 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.22420072 |
| 31 | Taste transduction_Homo sapiens_hsa04742 | 1.21954418 |
| 32 | Long-term potentiation_Homo sapiens_hsa04720 | 1.21888022 |
| 33 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.20698270 |
| 34 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.18575428 |
| 35 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.18379524 |
| 36 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.18114598 |
| 37 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.17383669 |
| 38 | Long-term depression_Homo sapiens_hsa04730 | 1.16200157 |
| 39 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.15960176 |
| 40 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.14779595 |
| 41 | Parkinsons disease_Homo sapiens_hsa05012 | 1.13616413 |
| 42 | Phototransduction_Homo sapiens_hsa04744 | 1.13476926 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.11917401 |
| 44 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.11517951 |
| 45 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.10466677 |
| 46 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.10079494 |
| 47 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.08497625 |
| 48 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.07193354 |
| 49 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.06550181 |
| 50 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.05238191 |
| 51 | Basal transcription factors_Homo sapiens_hsa03022 | 1.04946528 |
| 52 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.04275458 |
| 53 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.02906623 |
| 54 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.00941141 |
| 55 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.00336309 |
| 56 | Tight junction_Homo sapiens_hsa04530 | 1.00057569 |
| 57 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.99535393 |
| 58 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.97730293 |
| 59 | Prion diseases_Homo sapiens_hsa05020 | 0.97668558 |
| 60 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.96454634 |
| 61 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.94102556 |
| 62 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.93248566 |
| 63 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.92312259 |
| 64 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.92262621 |
| 65 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.90148635 |
| 66 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.89096813 |
| 67 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.87592089 |
| 68 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.86417602 |
| 69 | Adherens junction_Homo sapiens_hsa04520 | 0.85281328 |
| 70 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.82967648 |
| 71 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.82851501 |
| 72 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.82332151 |
| 73 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.82000845 |
| 74 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.81241498 |
| 75 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.80531317 |
| 76 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.79955587 |
| 77 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.79819154 |
| 78 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.79804726 |
| 79 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.78758784 |
| 80 | Legionellosis_Homo sapiens_hsa05134 | 0.77927461 |
| 81 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.76088947 |
| 82 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.75164425 |
| 83 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.73410520 |
| 84 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.73268933 |
| 85 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.72642795 |
| 86 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.71845894 |
| 87 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.71435221 |
| 88 | Mineral absorption_Homo sapiens_hsa04978 | 0.70167287 |
| 89 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.70132654 |
| 90 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.69661336 |
| 91 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.69646173 |
| 92 | Gap junction_Homo sapiens_hsa04540 | 0.69190570 |
| 93 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.68672467 |
| 94 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.68631552 |
| 95 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.68273501 |
| 96 | Pathways in cancer_Homo sapiens_hsa05200 | 0.67814589 |
| 97 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.67318255 |
| 98 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.66215971 |
| 99 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.65244529 |
| 100 | Huntingtons disease_Homo sapiens_hsa05016 | 0.64681993 |
| 101 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.64341109 |
| 102 | Focal adhesion_Homo sapiens_hsa04510 | 0.62381925 |
| 103 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.62359798 |
| 104 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61387567 |
| 105 | Melanoma_Homo sapiens_hsa05218 | 0.60519011 |
| 106 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.60070016 |
| 107 | Bile secretion_Homo sapiens_hsa04976 | 0.59935098 |
| 108 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.59685054 |
| 109 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.59015134 |
| 110 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.58565865 |
| 111 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.58022994 |
| 112 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.57421275 |
| 113 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.57214943 |
| 114 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.56597425 |
| 115 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.54059106 |
| 116 | Amoebiasis_Homo sapiens_hsa05146 | 0.54004603 |
| 117 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53631399 |
| 118 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.53506550 |
| 119 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52300903 |
| 120 | Peroxisome_Homo sapiens_hsa04146 | 0.50255606 |
| 121 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49968918 |
| 122 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.49915452 |
| 123 | Malaria_Homo sapiens_hsa05144 | 0.49300064 |
| 124 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.48719463 |
| 125 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.47338468 |
| 126 | Insulin resistance_Homo sapiens_hsa04931 | 0.47308306 |
| 127 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.47277526 |
| 128 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.46825681 |
| 129 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.46690302 |
| 130 | Axon guidance_Homo sapiens_hsa04360 | 0.46006588 |
| 131 | Melanogenesis_Homo sapiens_hsa04916 | 0.45589180 |
| 132 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.44759194 |
| 133 | Platelet activation_Homo sapiens_hsa04611 | 0.43618336 |
| 134 | ABC transporters_Homo sapiens_hsa02010 | 0.43226114 |
| 135 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.42439179 |
| 136 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.41802624 |
| 137 | Alzheimers disease_Homo sapiens_hsa05010 | 0.41243425 |
| 138 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.39823485 |
| 139 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.39308545 |
| 140 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.38388956 |
| 141 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.37764305 |

